Monarch Dental C. - eine spannende Aktie.

Beiträge: 11
Zugriffe: 553 / Heute: 2
NASDAQ 100 21.436,26 +1,60% Perf. seit Threadbeginn:   +1571,56%
 
Eskimato:

Monarch Dental C. - eine spannende Aktie.

 
08.05.02 01:17
Da mein Thread "Gesundheit = 1000 %" so unübersichtlich geworden ist, werde ich mal in Zukunft zu den Einzelaktien je einen Thread aufmachen.
Wer in meinen Thread mal reingelesen hat, wird sich wahrscheinlich an Monarch
Dental Partner erinnern, für die ich ein Kursziel von 6 Euro ausgegeben habe.
Heute hat M.D.P gleich zur Eröffnung 50% plus hingelegt. Von 3,30 auf 5 Dollar,
um dann bei 4,25 zu schliessen. Aber mit welcher Geschwindigkeit diese Aktie
hochläuft ist herrlich.
Monarch Dental C. - eine spannende Aktie. 657904cdchart.innovative-software.com/_common/...15f4bb05f7506ffe76" style="max-width:560px" >
Eskimato:

Frage an die Expertin Kicky

 
08.05.02 02:38
Hör mal Kicky, mein Englisch versagt wieder, Du hasts doch drauf und kannst Zahlen lesen. Heute gabs Zahlen bei M.D.P. , rechtfertigen die diesen Kurssprung? Kannst Du die mal überfliegen und Deine Meinung abgeben?
Habe mich brav bei der VHS für einen Kurs in Wirtschaftsenglisch angemeldet.
Wäre nett, vielleicht hast Du ja ein bisschen Zeit.

Monarch Dental Corporation Announces First Quarter Results for 2002  


DALLAS, May 7, 2002 /PRNewswire-FirstCall via COMTEX/ -- Monarch Dental
Corporation (Nasdaq: MDDS) today reported results for the first quarter ended
March 31, 2002.

Patient revenue, net was $47.6 million for the first quarter of 2002 compared to
$54.8 million reported for the same period last year and $51.6 million for the
fourth quarter of 2001. Net income for the first quarter of 2002 was $946,000,
or $0.42 per diluted share, compared to $401,000, or $0.18 per diluted share,
for the first quarter of 2001 and a net loss of $3.6 million, or $1.67 per
diluted share, for the fourth quarter of 2001.

The decline in revenue is due primarily to the sale of the Wisconsin market that
occurred on December 31, 2001. The Wisconsin operations accounted for $6.4
million of the Company's first quarter 2001 revenue and $6.1 million of the
Company's fourth quarter 2001 revenue. Excluding revenue from the Wisconsin
operations in 2001, revenue in the first quarter of 2002 increased $2.1 million,
or 4.4%, from the fourth quarter of 2001 and decreased $800,000, or 1.6%, from
the first quarter of 2001. The $800,000 decline in revenue from the first
quarter of 2001 was due in part to having one less business day in the current

quarter but primarily to the revenue declines in the Houston, Philadelphia,
Georgia and New Jersey markets. Revenue in these markets declined $1.6 million,
or 16.9%, while the remaining 13 markets reported an increase in revenue of
$857,000, or 2.2%, despite having one less business day in the current quarter.
The Colorado market, which has experienced dentist turnover and management
changes over the past twelve months, has experienced improved operating results
in the first quarter of 2002.

Net income for the first quarter of 2002 and 2001 as well as the fourth quarter
of 2001 contains several unusual items that make it difficult to compare
operating results from quarter to quarter. The results for the first quarter of
2002 include costs associated with the Company's evaluation of strategic
alternatives, net of tax, of $32,000, or $0.01 per diluted share, but do not
include any amortization of goodwill as specified by the Statement of Financial
Accounting Standards (SFAS) No. 142 "Goodwill and Other Intangible Assets" which
became effective January 1, 2002. The results of the first quarter of 2001
include strategic alternative costs, net of tax, of $158,000, or $0.07 per
diluted share, amortization of goodwill, net of tax, of $812,000, or $0.36 per
diluted share, and net income after tax from the Wisconsin operations of
$438,000, or $0.20 per diluted share. The results of the fourth quarter of 2001
include the loss on sale of a subsidiary of $1.1 million, or $0.49 per diluted
share, that was not deductible for tax purposes, a charge related to unbilled
orthodontic receivables, net of tax, of $673,000, or $0.31 per diluted share,
amortization of goodwill, net of tax, of $1.1 million, or $0.50 per diluted
share, and net income after tax from the Wisconsin operations of $259,000, or
$0.12 per diluted share.

Excluding these items, net income for the first quarter of 2002 was $978,000, or
$0.44 per diluted share, compared to $933,000, or $0.42 per diluted share, for
the first quarter of 2001 and a net loss of $1.1 million, or $0.49 per diluted
share, for the fourth quarter of 2001. The Company attributed the increase in
net income in the first quarter of 2002 compared to the same quarter in 2001 to
the reduction in interest expense resulting from the reduction in outstanding
debt during 2001 and the first quarter of 2002. For the period June 1, 2001
through April 30, 2002, the Company has reduced its bank debt by approximately
$16.1 million. The Company attributed the increase in net income from the fourth
quarter of 2001 to the increase in revenue and decreases in expenses such as
clinical and other salaries, other operating expenses and interest expense.

Cash flow from operations was $4.4 million in the first quarter of 2002 compared
to $6.5 million for the same period last year and $1.2 million in the fourth
quarter of 2001.

W. Barger Tygart, Chairman and Chief Executive Officer, stated, "We are pleased
with the financial results of the first quarter. Except for the continued
challenges in the Houston, Philadelphia, Georgia and New Jersey markets, the
Company experienced combined revenue growth in the remaining 13 markets of 2.2%
compared to the same quarter in 2001, despite having one less business day, and
combined margin growth in the 13 markets of 14.1%. We are starting to see some
margin improvement as a result of our cost reduction efforts at the corporate
office and in the markets. We are also pleased to see that the Colorado market
is showing signs of stronger financial performance. Our efforts for the
remainder of 2002 will be focused on restoring the Houston, Philadelphia,
Georgia and New Jersey markets to their previous levels of financial
performance."

The Company will hold a conference call Tuesday, May 7, 2002, at 5:00 p.m.
Eastern Time to further discuss its results for the first quarter ended March
31, 2002 and business highlights. The conference call will be broadcast live
over the Internet and will be hosted on the Company's web site located at
www.monarchdental.com. In addition, the Company may answer questions
concerning business and financial developments, trends and other business and
financial matters affecting the Company, some of the responses to which may
contain information that has not been previously disclosed.

Monarch Dental currently manages 155 dental offices serving 17 markets in 13
states. The Company seeks to build geographically dense networks of dental
providers primarily by expanding within its existing markets.

Pursuant to the safe harbor provisions of the Private Securities Litigation Act
of 1995, the Company notes that statements contained in this news release that
are not based on historical facts are forward-looking statements, including the
statements regarding improving future operating results in our Houston,
Philadelphia, Georgia, New Jersey, and Colorado markets, achieving efficiency
gains and improving revenues and operating margins, and such statements are
subject to uncertainties and risks that could cause actual results to differ
from those projected or implied by such statements. These include, but are not
limited to, the risk that the Company will not be able to consummate a strategic
transaction, the risk that the Company will not be able to renegotiate its loan
agreement on acceptable terms or maintain sufficient liquidity to fund future
operations, the risk that the Company will not receive a waiver of its current
defaults under its Credit Facility and the related risks that the Company's
lenders will accelerate the maturity of its indebtedness or apply the Company's
cash balances to debt repayment, risks associated with the operating performance
of the Houston, Philadelphia, Georgia, New Jersey, and Colorado markets, risks
associated with the change of status or departure of key management personnel,
risks associated with state regulatory compliance in the dental industry, the
reimbursement rates for dental services, and other risks detailed in the
Company's Securities and Exchange Commission filings.



                  MONARCH DENTAL CORPORATION AND SUBSIDIARIES

                       CONSOLIDATED STATEMENTS OF INCOME

                                  (Unaudited)



                                               Three months ended March 31,

                                                  2002              2001



   Patient revenue, net                       $47,577,468       $54,813,883

   Operating expenses:

     Provider salaries and benefits            16,822,462        18,601,871

     Clinical and other salaries and benefits  12,276,230        14,885,660

     Dental supplies                            2,403,827         2,666,288

     Laboratory fees                            2,729,851         2,891,498

     Occupancy                                  2,276,874         2,672,004

     Advertising                                  466,962           612,844

     Other operating expenses                   5,775,852         5,921,246

     Strategic alternative costs                   51,925           259,772

     Depreciation and amortization              1,186,671         2,764,832

                                               43,990,654        51,276,015

   Operating income                             3,586,814         3,537,868

   Interest expense, net                        1,978,115         2,561,483

   Minority interest in

    consolidated subsidiaries                      57,097            72,907

   Income before income taxes                   1,551,602           903,478

   Income taxes                                   605,129           502,423

   Net income                                    $946,473          $401,055

   Net income per common share                      $0.44             $0.19

   Net income per common share -

    assuming dilution                               $0.42             $0.18

   Weighted average number of

    common shares outstanding                   2,170,823         2,160,058

   Weighted average number of common and

    common equivalent shares outstanding        2,236,466         2,225,150

SOURCE Monarch Dental Corporation



CONTACT:          Lisa Peterson, Chief Financial and Administrative Officer of

                 Monarch Dental Corporation, +1-972-361-8430; Investors - Lanie Fladell,

                 Media - Dan Budwick, both of Morgen-Walke Associates, +1-212-850-5600, for

                 Monarch Dental Corporation



URL:              www.monarchdental.com

www.prnewswire.com


Copyright (C) 2002 PR Newswire.  All rights reserved.





KEYWORD:          Texas

INDUSTRY KEYWORD: HEA

SUBJECT CODE:     ERN

                 CCA




 

DJIA  9,836.55   28.51

Nasdaq  1,573.82   4.66

S&P 500  1,049.49   3.18

10 Yr Bond  5.07   0.01



$7 Trades, Rated #1 Broker

Keyword Search  
Enter Keyword
 









--------------------------------------------------

Eskimato:

Es geht wieder los, 100 % in 3 Tagen.

 
14.09.02 05:34


Monarch Dental C. - eine spannende Aktie. 784019chart4.onvista.de/OnVista/....html?PERIOD=4&ID_NOTATION=10327" style="max-width:560px" >
Sinus:

wollen wir wetten dass das

 
14.09.02 05:37
Ding auf sieben läuft und dann gnadenlos auf 1 (eins) abstürtzt? (aber nur wenn ich jetzt aufspringe)
Eskimato:

Wären 50% Gewinn bei 7. o.T.

 
14.09.02 05:38
Eskimato:

So sehen Traumaktien aus, Gewinne garantiert:

 
14.09.02 05:45
Bis zum Ende des Jahres laufen diese Aktien garantiert zu neuen Höhen, allerdings würde ich Highflyer Ende des Jahres abstossen und die Entwicklung im neuen Jahr abwarten.


Monarch Dental C. - eine spannende Aktie. 784023chart4.onvista.de/OnVista/...tml?PERIOD=4&ID_NOTATION=3081758" style="max-width:560px" >
Sinus:

Moin moin, bist aber früh

 
14.09.02 05:49
unterwegs. Also zock with Monarch on monday? We expect earnings around 50 per 100!
Eskimato:

Komme von der Nachtschicht, ist halt meine Zeit. o.T.

 
14.09.02 05:51
Sinus:

bin eben hoch weil ich stress mit meiner

 
14.09.02 05:57
kleinen habe, hab bnur eine h geschlafen und bin dodahl dursch
de wind.  
Sinus:

ochso, hab och dodaol vorgesswen

 
14.09.02 06:00
meene Sxhbrachbropleme zu rwähne
Eskimato:

Ich poste und bekomme meine Antworten

 
14.09.02 06:21
nach ca. 36 Stunden. Nur stammele ich selten dummes Zeug daher. Mit Deinen Problemen kann ich nichts anfangen. Für mich ist dies nen Aktienboard. Wenn Du Ahnung hast, melde Dich beim Börsenspiel von Infomia an, wir vergleichen dann
unsere Depots, gelle?
Die Preise sind ordentlich, je Spielrunde gibts nen Mini zu gewinnen, einer ist für mich reserviert.
Es gibt keine neuen Beiträge.


Börsen-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen

Neueste Beiträge aus dem Nasdaq 100 Forum

Wertung Antworten Thema Verfasser letzter Verfasser letzter Beitrag
31 5.774 Intel - ein kurzfristiger Trade? Anti Lemming Bilderberg 17:55
  440 Micron Technology kague Fu Hu 06.01.25 16:01
10 87 Editas Medicine macos Vassago 13.12.24 16:11
44 8 360 digitech QFin A2PDLQ slim_nesbit Silbergroschen 09.12.24 15:56
11 746 ABUS RNAi Play macos schmidin01 14.11.24 13:55

--button_text--